Super Avana

Super Avana

Price from 189.00 $
Product dosage: 160mg
Package (num)Per pillPriceBuy
36$5.29$190.48 $190.48 (0%)🛒 Add to cart
60$5.07$317.46 $304.36 (4%)🛒 Add to cart
88$4.96$465.61 $436.39 (6%)🛒 Add to cart
120
$4.90 Best per pill
$634.93 $587.56 (7%)🛒 Add to cart

Similar products

Super Avana: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation

Super Avana is a prescription medication combining two active ingredients, Avanafil and Dapoxetine, designed to address both erectile dysfunction (ED) and premature ejaculation (PE) in adult men. This dual-mechanism treatment offers a comprehensive approach to common sexual health concerns, working to improve erectile function while simultaneously extending intravaginal ejaculatory latency time. It is intended for use under medical supervision, following a thorough evaluation of the patient’s health status and contraindications. Super Avana should be taken only as prescribed, and individuals are advised to discuss their full medical history with a healthcare provider prior to initiation.

Features

  • Contains Avanafil 100mg and Dapoxetine 60mg per tablet
  • Rapid onset of action, typically within 15–30 minutes
  • Dual mechanism: phosphodiesterase type 5 (PDE5) inhibition and selective serotonin reuptake inhibition
  • Formulated for on-demand use prior to anticipated sexual activity
  • Manufactured under strict pharmaceutical quality control standards

Benefits

  • Improves the ability to achieve and maintain an erection sufficient for satisfactory sexual performance
  • Significantly prolongs time to ejaculation, enhancing sexual endurance and control
  • May contribute to increased sexual confidence and reduced performance-related anxiety
  • Addresses two common sexual dysfunctions with a single treatment regimen
  • Offers a discreet and convenient therapeutic option for dual symptom management
  • May improve overall sexual satisfaction for both partners

Common use

Super Avana is indicated for the treatment of erectile dysfunction and premature ejaculation in adult men. It is prescribed for individuals who experience difficulty achieving or maintaining an erection adequate for sexual intercourse, concurrently with the inability to control ejaculation, resulting in personal distress or interpersonal difficulty. The medication is intended for use prior to anticipated sexual activity and is not recommended for continuous daily administration. Patients should engage in sexual stimulation for the erectile response to occur effectively.

Dosage and direction

The recommended dosage is one tablet taken approximately 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a glass of water, and may be taken with or without food, though high-fat meals may delay onset of action. The medication should not be taken more than once in a 24-hour period. Healthcare providers may adjust the dosage based on individual tolerance and therapeutic response. Patients are advised to avoid grapefruit juice while using this medication, as it may increase the risk of side effects.

Precautions

Patients should undergo a thorough medical evaluation before initiating treatment with Super Avana. Cardiovascular status should be assessed, as sexual activity carries potential cardiac risk. Those with pre-existing cardiovascular conditions should use this medication with caution. Orthostatic hypotension may occur; patients are advised to rise slowly from a sitting or lying position. Caution is recommended when engaging in activities requiring alertness, such as driving or operating machinery, due to potential dizziness or syncope. Alcohol consumption should be limited as it may increase the risk of adverse effects.

Contraindications

Super Avana is contraindicated in patients with known hypersensitivity to Avanafil, Dapoxetine, or any component of the formulation. Concurrent use with nitrates or nitric oxide donors in any form is absolutely contraindicated due to the risk of severe hypotension. The medication is contraindicated in patients with severe hepatic impairment, significant cardiovascular disease, unstable angina, or recent history of stroke or myocardial infarction. It should not be used in patients taking monoamine oxidase inhibitors (MAOIs), thioridazine, or other potent CYP3A4 inhibitors.

Possible side effects

Common side effects may include headache, dizziness, flushing, nasal congestion, nausea, and insomnia. Less frequently reported effects include visual disturbances, palpitations, increased blood pressure, diarrhea, and anxiety. Priapism (prolonged and painful erection lasting more than 4 hours) requires immediate medical attention to prevent permanent tissue damage. Sudden hearing loss or vision changes, though rare, warrant discontinuation and prompt medical evaluation. Most side effects are mild to moderate in intensity and tend to diminish with continued use.

Drug interaction

Super Avana may interact with alpha-blockers, antihypertensive medications, and other drugs affecting blood pressure, potentially enhancing hypotensive effects. Concurrent use with strong CYP3A4 inhibitors (such as ketoconazole, ritonavir) may significantly increase plasma concentrations. Combination with other PDE5 inhibitors or treatments for erectile dysfunction is not recommended. Serotonergic drugs, including antidepressants, tramadol, and triptans, may increase the risk of serotonin syndrome. Patients should disclose all current medications, including over-the-counter drugs and herbal supplements, to their healthcare provider.

Missed dose

As Super Avana is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply. Patients should take one tablet approximately 30 minutes before anticipated sexual activity. The medication should not be taken more frequently than once per 24-hour period. If sexual activity does not occur after taking the medication, no additional dose should be taken until the next anticipated sexual encounter.

Overdose

In case of suspected overdose, immediate medical attention should be sought. Symptoms may include severe headache, dizziness, syncope, prolonged erection, and cardiovascular effects. Supportive measures should be implemented, including monitoring of vital signs and symptomatic treatment. Priapism requires urgent urological intervention to prevent irreversible damage. There is no specific antidote for Super Avana overdose; treatment focuses on supportive care and management of presenting symptoms.

Storage

Store at room temperature (15–30°C) in the original packaging, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. The medication should not be stored in bathrooms or other areas with high humidity. Proper disposal of unused medication should follow local regulations or through take-back programs to prevent environmental contamination or accidental ingestion.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Super Avana is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the described benefits. Patients should consult with their healthcare provider for personalized medical advice, including assessment of potential risks and benefits based on their specific health condition. Never initiate or discontinue medication without professional medical guidance.

Reviews

Clinical studies demonstrate that Super Avana effectively improves erectile function and延长s intravaginal ejaculatory latency time in the majority of patients. In randomized controlled trials, significant improvements were observed in International Index of Erectile Function (IIEF) scores and perceived control over ejaculation. Patient-reported outcomes indicate high satisfaction rates with both the erectile response and ejaculatory control aspects of treatment. Some users report mild side effects that typically diminish with continued use. Long-term efficacy and safety data continue to be collected through post-marketing surveillance and ongoing clinical research.